Overview

A Phase III Study Evaluate the Efficacy and Safety of BAT1406 and Humira

Status:
Completed
Trial end date:
2018-05-31
Target enrollment:
Participant gender:
Summary
A Phase III Study Evaluate the Efficacy and Safety of BAT1406 and Humira
Phase:
Phase 3
Details
Lead Sponsor:
Bio-Thera Solutions
Treatments:
Adalimumab